Integration
What are peptides, and are they worth it?
Synthetic peptides mimic the body's own signalling molecules — but that covers two very different categories.
- 1The synthetic peptides discussed in longevity and performance circles are lab-made molecules engineered to mimic a signalling peptide the body already produces on its own — binding the same receptors and triggering the same effect — tissue repair, appetite suppression, a growth-hormone pulse — that the body's own version would, just delivered directly rather than left to the body's own production. That still covers two very different categories, though, and conflating them is where most confusion starts.
- 2GLP-1 receptor agonists (semaglutide, tirzepatide) are peptide-based drugs with genuinely strong randomised trial evidence — real weight loss, well-characterised side effects — and worth it if a doctor confirms the medical case fits. Covered separately in the Food & Nutrition guide.
- 3Compounds like BPC-157 and TB-500 sit at what this site's longevity guide calls the "unregulated fringe" — claimed tissue-repair and anti-inflammatory effects with essentially no robust human trial data, sold outside standard pharmaceutical oversight. Not worth betting on yet — the evidence just isn't there.
- 4Regulatory status here is genuinely in flux: the FDA placed BPC-157 on its Category 2 safety-risk list in September 2023, then removed it from that list in April 2026 pending a Pharmacy Compounding Advisory Committee review scheduled for July 23, 2026 — a reversal of restriction, not a finding of proven safety.
- 5If you're considering a compound in the unregulated category, that's a conversation for a physician, not a forum — the missing data cuts both ways, so neither the benefits nor the safety are established.